JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF Stock Forecast, Price & News

Wall Street analysts have given JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF's stock was trading at $26.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BBSA stock has decreased by 0.2% and is now trading at $25.9799.
View which stocks have been most impacted by COVID-19.

Based on aggregate information from My MarketBeat watchlists, some companies that other JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF investors own include Inovio Pharmaceuticals (INO), Protalix BioTherapeutics (PLX), Allied Healthcare Products (AHPI), AEGON (AGN), Aeglea BioTherapeutics (AGLE), Aerie Pharmaceuticals (AERI), Adverum Biotechnologies (ADVM), Adaptimmune Therapeutics (ADAP), ACADIA Pharmaceuticals (ACAD) and Abbott Laboratories (ABT).

JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF trades on the BATS under the ticker symbol "BBSA."

Shares of BBSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BBSA stock can currently be purchased for approximately $25.98.